Flerie AB FLERIE

OMXSTO · Sweden · Health Technology

SEK 16.10-0.20 (-1.23%)

Market closed· Oct 1, 2026, 3:29 PM UTC· SEK · Data may be delayed

Company news

Yahoo FinanceSep 30, 2026

AnaCardio raises €62.5 million Series B financing to advance transformational novel therapy in heart failure towards Phase 3 readiness

Financing co-led by Novo Holdings and the Ljungström family office, with participation from the originator Helsinn, existing investors Pureos Bioventures, Sound Bioventures, Industrifonden, Flerie, LLD Nybohov Invest AB and new investor Innovestor Life ScienceProceeds will fund Phase 2b development of AC01, a first-in-class oral therapy designed to improve cardiac contractility and outcomes in patients with advanced heart failurePhase 1b/2a GOAL-HF1 study demonstrated clinical proof of concept,

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.